Stock Information
Phathom Pharmaceuticals Inc (PHAT)
Ticker Symbol: PHAT
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $893.50 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -3.8125
Revenue (TTM): $2.01 M
Dividend Yield: N/A%
ROE: -232.78%
Latest News
-
Guggenheim Maintains Buy on Phathom Pharmaceuticals, Raises Price Target to $25
Fri, Feb 27, 2026 11:47 AM
-
Phathom Pharmaceuticals, Inc. 2025 Q4 - Results - Earnings Call Presentation
Fri, Feb 27, 2026 6:33 AM
-
Phathom Pharmaceuticals, Inc. (PHAT) Q4 2025 Earnings Call Transcript
Thu, Feb 26, 2026 5:09 PM
-
Phathom Pharmaceuticals (NASDAQ:PHAT) Q4 2025 Earnings: Revenue Beat and Narrowed Losses Signal Path to Profitability
Thu, Feb 26, 2026 1:27 PM
-
Phathom Pharmaceuticals shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY26 sales guidance above estimates.
Thu, Feb 26, 2026 11:35 AM
-
Phathom Pharmaceuticals Sees FY2026 Sales $320.000M-$345.000M vs $314.481M Est
Thu, Feb 26, 2026 8:02 AM
-
Phathom Pharmaceuticals Earnings Review: Q4 Summary
Thu, Feb 26, 2026 8:02 AM
-
Phathom Pharmaceuticals Q4 Adj. EPS $(0.08) Beats $(0.38) Estimate, Sales $57.584M Beat $57.050M Estimate
Thu, Feb 26, 2026 8:01 AM
-
Earnings Scheduled For February 26, 2026
Thu, Feb 26, 2026 7:11 AM
Key Financials
Financial data not available
